MetaCap

Illumina Quarterly Income Statement

NASDAQ: ILMNHealth CareMedical SpecialitiesUSD

278.17+13.60 (+5.14%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Illumina revenue and earnings

In the quarter ended Jun 28, 2026, Illumina generated $1.16 billion in revenue, up 9.4% from the same quarter a year earlier. Net income was $207.0 million (-11.9% year over year), for a net margin of 17.9% versus a median of 13.8% in the prior 5 quarters. Gross margin was 66.4% (up from 65.6%) and operating margin 21.1%.

Diluted earnings per share came in at $1.35, down from $1.49.

Summary generated from market data by MetaCap's automated system. Methodology

Illumina income statement (quarterly)

Illumina quarterly income statement
Quarter (USD)Q2 20262026-06-28Q1 20262026-03-29Q4 20252025-12-28Q3 20252025-09-28Q2 20252025-06-29Q1 20252025-03-30Q4 20242024-12-29Q3 20242024-09-29Q2 20242024-06-30Q1 20242024-03-31Q4 20232023-12-31Q3 20232023-10-01
Revenue1.16B1.09B1.16B1.08B1.06B1.04B1.10B1.08B1.11B1.08B1.12B1.12B
Revenue growth (YoY)+9.44%+4.80%+4.98%+0.37%-4.77%-3.25%-1.60%-3.49%-5.44%-1.01%+3.60%+0.36%
Cost of Revenue389.00M370.00M400.00M351.00M364.00M358.00M376.00M335.00M391.00M409.00M448.00M435.00M
Gross Profit770.00M721.00M759.00M733.00M695.00M683.00M728.00M745.00M721.00M667.00M674.00M684.00M
Operating Expenses525.00M512.00M558.00M506.00M481.00M519.00M553.00M4.00M2.36B778.00M838.00M1.44B
Research & Development252.00M240.00M239.00M229.00M247.00M252.00M256.00M253.00M325.00M339.00M341.00M315.00M
Selling, General & Admin273.00M272.00M309.00M277.00M234.00M267.00M279.00M239.00M147.00M439.00M485.00M303.00M
Operating Income245.00M209.00M201.00M227.00M214.00M164.00M175.00M741.00M-1.64B-111.00M-164.00M-754.00M
Interest Expense24.00M24.00M26.00M25.00M25.00M25.00M25.00M36.00M20.00M18.00M18.00M19.00M
Other Income (Expense)15.00M-52.00M176.00M-7.00M92.00M18.00M12.00M-21.00M-339.00M2.00M-3.00M-28.00M
Pretax Income260.00M157.00M377.00M220.00M306.00M182.00M187.00M720.00M-1.98B-109.00M-167.00M-782.00M
Income Tax53.00M23.00M43.00M70.00M71.00M51.00M015.00M12.00M17.00M8.00M-28.00M
Net Income207.00M134.00M334.00M150.00M235.00M131.00M186.00M705.00M-1.99B-126.00M-176.00M-754.00M
Net Income growth (YoY)-11.91%+2.29%+79.57%-78.72%—————-4300.00%——
EPS (Basic)1.370.882.170.981.490.831.154.43-12.48-0.79-1.11-4.77
EPS (Diluted)1.350.872.160.981.490.821.164.42-12.48-0.79-1.11-4.77
Shares Outstanding (Basic)151.00M153.00M—153.00M157.00M159.00M—159.00M159.00M159.00M—158.00M
Shares Outstanding (Diluted)153.00M154.00M—154.00M157.00M159.00M—160.00M159.00M159.00M—158.00M
EBITDA296.00M260.00M267.00M294.00M282.00M233.00M246.00M811.00M-1.53B-3.00M-104.00M-695.00M
Gross Margin66.44%66.09%65.49%67.62%65.63%65.61%65.94%68.98%64.84%61.99%60.07%61.13%
Operating Margin21.14%19.16%17.34%20.94%20.21%15.75%15.85%68.61%-147.21%-10.32%-14.62%-67.38%
Net Margin17.86%12.28%28.82%13.84%22.19%12.58%16.85%65.28%-178.78%-11.71%-15.69%-67.38%

This table shows 12 quarterly periods of Illumina's income statement, from Q2 2026 back to Q3 2023, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow ILMN's reporting calendar. What is a income statement?

More financial data